Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction
Martin Negreira-Caamaño,
Jorge Martínez-Del Río,
Alfonso Morón-Alguacil,
Pedro Pérez-Díaz,
Jesus Piqueras-Flores
Affiliations
Martin Negreira-Caamaño
Cardiology Department, University General Hospital of Ciudad Real, Spain
Jorge Martínez-Del Río
Cardiology Department, University General Hospital of Ciudad Real, Spain
Alfonso Morón-Alguacil
Cardiology Department, University General Hospital of Ciudad Real, Spain
Pedro Pérez-Díaz
Cardiology Department, University General Hospital of Ciudad Real, Spain; Cardiomyopathies and Inherited Disease Unit, Cardiology Department, University General Hospital of Ciudad Real, Spain
Jesus Piqueras-Flores
Cardiology Department, University General Hospital of Ciudad Real, Spain; Cardiomyopathies and Inherited Disease Unit, Cardiology Department, University General Hospital of Ciudad Real, Spain; Medicine Faculty, Castilla La-Mancha University, Ciudad Real, Spain; Corresponding author.